Zocovas Gold 75mg/20mg/75mg Capsule is a combination pharmaceutical formulation containing Aspirin (75mg), Atorvastatin (20mg), and Clopidogrel (75mg), designed for the management and prevention of cardiovascular diseases. Aspirin, an antiplatelet agent, inhibits cyclooxygenase enzymes, reducing thromboxane A2 production and thereby preventing platelet aggregation. Atorvastatin, a statin class lipid-lowering agent, competitively inhibits HMG-CoA reductase, leading to decreased cholesterol synthesis and improved lipid profiles, which contributes to a reduction in atherosclerotic plaque progression. Clopidogrel, another antiplatelet agent, selectively inhibits the ADP receptor on platelet cell membranes, further preventing platelet activation and aggregation. The combined action of these agents provides a synergistic effect in reducing the risk of myocardial infarction, stroke, and other thrombotic cardiovascular events, particularly in patients with established coronary artery disease or those at high risk. Zocovas Gold is indicated for secondary prevention in patients with a history of acute coronary syndrome, ischemic stroke, or peripheral arterial disease. The medication should be used under medical supervision, with monitoring for potential adverse effects such as bleeding, hepatic dysfunction, or myopathy. Contraindications include active bleeding, hypersensitivity to any component, and severe hepatic impairment.